cyclopentane has been researched along with 1-aminocyclopentane-1,3,4-tricarboxylic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acher, FC; Azerad, R; Brabet, IN; Fagni, L; Pin, JP; Tellier, FJ | 1 |
| Konieczny, J; Kuter, K; Ossowska, K; Pilc, A; Wardas, J | 1 |
| Kłodzińska, A; Neuville, P; Palucha-Poniewiera, A; Pilc, A; Schann, S; Stachowicz, K | 1 |
| Amalric, M; Jouve, L; Kerkerian-Legoff, L; Lopez, S; Salin, P; Turle-Lorenzo, N | 1 |
| Domin, H; Gołembiowska, K; Jantas, D; Kamińska, K; Smiałowska, M; Zięba, B | 1 |
| Boguszewski, PM; Domin, H; Jantas, D; Kozniewska, E; Przykaza, Ł; Śmiałowska, M | 1 |
| Boguszewski, PM; Domin, H; Kozniewska, E; Przykaza, Ł; Śmiałowska, M | 1 |
7 other study(ies) available for cyclopentane and 1-aminocyclopentane-1,3,4-tricarboxylic acid
| Article | Year |
|---|---|
Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
Topics: Animals; Binding, Competitive; Cell Line; Cells, Cultured; Cerebellum; Cyclopentanes; GABA Agonists; GABA Antagonists; Humans; Indicators and Reagents; Inositol; Inositol Phosphates; Kinetics; Mice; Molecular Conformation; Molecular Structure; Neurons; Receptors, Metabotropic Glutamate; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Transfection; Tricarboxylic Acids | 1997 |
The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Topics: Animals; Corpus Striatum; Cyclopentanes; Dopamine Antagonists; Dose-Response Relationship, Drug; Enkephalins; Excitatory Amino Acid Agonists; Gene Expression Regulation; Glutamic Acid; Haloperidol; Male; Neural Pathways; Opioid Peptides; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger; Substantia Nigra; Synaptic Transmission; Tricarboxylic Acids; Up-Regulation | 2007 |
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cyclopentanes; Depression; Flumazenil; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Injections, Intraperitoneal; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological; Tricarboxylic Acids | 2009 |
Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
Topics: Animals; Cyclopentanes; Disease Models, Animal; Excitatory Amino Acid Agonists; Male; Neural Pathways; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Stereoisomerism; Substantia Nigra; Subthalamic Nucleus; Tricarboxylic Acids | 2012 |
Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Cyclopentanes; Excitatory Amino Acid Agonists; Extracellular Space; Glutamic Acid; Hippocampus; Kainic Acid; Male; Mice; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Metabotropic Glutamate; Tricarboxylic Acids | 2014 |
Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
Topics: Animals; Brain Ischemia; Cells, Cultured; Cyclopentanes; Disease Models, Animal; Excitatory Amino Acid Agonists; L-Lactate Dehydrogenase; Male; Mice; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stroke; Tricarboxylic Acids | 2016 |
Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension.
Topics: Animals; Brain; Brain Ischemia; Cyclopentanes; Essential Hypertension; Gait; Male; Neuroprotective Agents; Random Allocation; Rats, Inbred SHR; Receptors, Metabotropic Glutamate; Sensation; Stroke; Tricarboxylic Acids | 2018 |